- Home
- NXPLW vs SBS Comparison
NXPLW vs SBS Comparison
Compare NXPLW & SBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- SBS
- Stock Information
- Founded
- NXPLW N/A
- SBS 1954
- Country
- NXPLW United States
- SBS Brazil
- Employees
- NXPLW 166
- SBS N/A
- Industry
- NXPLW Telecommunications Equipment
- SBS Water Supply
- Sector
- NXPLW Telecommunications
- SBS Utilities
- Exchange
- NXPLW Nasdaq
- SBS Nasdaq
- Market Cap
- NXPLW N/A
- SBS N/A
- IPO Year
- NXPLW N/A
- SBS 2002
- Fundamental
- Price
- NXPLW N/A
- SBS $18.72
- Analyst Decision
- NXPLW
- SBS
- Analyst Count
- NXPLW 0
- SBS 0
- Target Price
- NXPLW N/A
- SBS N/A
- AVG Volume (30 Days)
- NXPLW 6.4K
- SBS 1.4M
- Earning Date
- NXPLW 03-31-2025
- SBS 05-08-2025
- Dividend Yield
- NXPLW N/A
- SBS 1.14%
- EPS Growth
- NXPLW N/A
- SBS 171.87
- EPS
- NXPLW N/A
- SBS 2.27
- Revenue
- NXPLW $66,482,000.00
- SBS $5,844,148,990.00
- Revenue This Year
- NXPLW N/A
- SBS N/A
- Revenue Next Year
- NXPLW N/A
- SBS $14.85
- P/E Ratio
- NXPLW N/A
- SBS $8.22
- Revenue Growth
- NXPLW 179.89
- SBS 41.35
- 52 Week Low
- NXPLW $0.25
- SBS $13.10
- 52 Week High
- NXPLW $0.26
- SBS $18.95
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- SBS 61.66
- Support Level
- NXPLW N/A
- SBS $18.09
- Resistance Level
- NXPLW N/A
- SBS $18.58
- Average True Range (ATR)
- NXPLW 0.00
- SBS 0.50
- MACD
- NXPLW 0.00
- SBS 0.05
- Stochastic Oscillator
- NXPLW 0.00
- SBS 90.53
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.